OCS

Oculis Holding Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 4/10
  • Value↓ 0/10
Oculis Holding sales and earnings growth
OCS Growth
Neutral
  • Revenue Y/Y↑ 74.78%
  • EPS Y/Y↑ 10.85%
  • FCF Y/Y↓ -35.52%
Oculis Holding gross and profit margin trends
OCS Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -8253.30%
  • ROIC 5Y↓ 0.00%
Oculis Holding net debt vs free cash flow
OCS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -118.0

Oculis Holding stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗